In myeloma cells without del(8)(p21), bortezomib alone and soluble TRAIL/APO2L alone efficiently induced a decrease in CD38+/CD138Bright MM cells as well as apoptosis. This evidence concerns the gene CD38 and Miyoshi myopathy.